期刊文献+

重症药疹41例临床分析 被引量:7

Clinical analysis of 41 cases of severe drug eruption
下载PDF
导出
摘要 目的探讨重症药疹的发生规律、临床特点和治疗措施。方法对2009年1月-2014年12月广东省人民医院皮肤科收治的41例重症药疹患者的发病年龄、疹型、致敏药物、潜伏期、住院时间和糖皮质激素使用剂量等临床资料进行回顾性分析。结果重症药疹中以重症多形红斑型药疹最多见(63.41%),其次是中毒性表皮坏死松解型药疹(26.83%),剥脱性皮炎型药疹排第3位(9.76%),其中以剥脱性皮炎型药疹的潜伏期最长,各型重症药疹的发病年龄、住院时间和使用糖皮质激素剂量比较差异无统计学意义(P〉0.05);抗痛风药别嘌醇在致敏药物中居首位(51.22%),其次是抗癫痫药卡马西平(24.39%)。结论不同类型重症药疹的临床表现各异,内脏器官损伤发生率高,与疾病转归有关;临床上应谨慎使用别嘌醇、卡马西平等高发致敏药物;早期足量使用糖皮质激素并联合静脉用人免疫球蛋白治疗可以取得较好的临床效果。 Objective To investigate the occurrence regularity, clinical feature and treatment of severe drug eruption.Methods 41 severe drug eruption inpatients in the Department of Dermatology of Guangdong General Hospital from January 2009 to December 2014 were selected. Age, eruptive form, allergic drug, incubation period, hospitalization time and corticosteroid dosage were studied. Results Steven-Johnson syndrome was the most common severe drug eruption(63.41%), next was toxic epidermal necrolysis(26.83%) and exfoliative dermatitis(9.76%). Exfoliative dermatitis had the longest latent period. There were no significant differences among the different severe drug eruptions of ages, hospitalization time and corticosteroid dosage(P 〉0.05). Allopurinol(51.22%) and carbamazepine(24.39%) were the most common causative drugs. Conclusion There were various clinical manifestations with different types of severe drug eruptions, the high incidence of organ damage which is related to the prognosis of the disease. The indication of using allopurinol and carbamazepine should be weighed further. The curative effect may be better after early and sufficiently using corticosteroid combined with intravenous immune globulin.
作者 林静 董秀芹
出处 《中国医药导报》 CAS 2016年第11期134-137,共4页 China Medical Herald
基金 广东省医学科学技术研究基金项目(A2015148)
关键词 重症药疹 临床分析 别嘌醇 Severe drug eruption Clinical analysis Allopurinol
  • 相关文献

参考文献14

二级参考文献96

  • 1汪小柳,李锐,方红,郭田章.38例重症药疹临床分析[J].实用皮肤病学杂志,2010,3(3):137-140. 被引量:15
  • 2李常兴,张锡宝,吴志华.静脉用免疫球蛋白在皮肤科临床的应用及进展[J].国外医学(皮肤性病学分册),2005,31(3):171-173. 被引量:16
  • 3胡成,吴建华,顾军.重症药疹24例临床分析[J].中国皮肤性病学杂志,2006,20(11):680-680. 被引量:9
  • 4何志新,甘戈,王宝玺.539例药疹临床分析[J].中华皮肤科杂志,2006,39(12):703-705. 被引量:40
  • 5Kirtschig G,Khumalo NP.Management of bullous pemphigoid:recommendations for immunomodulatory treatments.Am J Clin Dermatol,2004,5(5):319-326.
  • 6Harman KE,Albert S,Black MM,et al.Guidelines for the management of pemphigus vulgaris.Br J Dermatol,2003,149 (5):926-937.
  • 7Perez OA,Patton T.Novel therapies for pemphigus vulgaris:an overview.Drugs Aging,2009,26(10):833-46.
  • 8Yu Z, Lennon VA. Mechanism of intravenous immune globulin therapy in antibody-mediated autoimmune diseases. N Engl J Med, 1999,340:227 - 228.
  • 9Hansen RJ, Bahhasar JP. Mechanisms of IVIG action in immune thromboeytopenic purpura. Clin Lab, 2004, 50:133 -140.
  • 10Sultan Y, Kazatehkine MD, Maisonneuve P, et al. Anti-idiotypie suppression of autoantibodies to factor Ⅷ (antihaemophilic factor)by high-dose intravenous gammaglobulin. Lancet, 1984, 2:765.

共引文献220

同被引文献57

引证文献7

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部